Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

2.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
3.

Treatment of multidrug-resistant tuberculosis in Thailand.

Maranetra KN.

Chemotherapy. 1996;42 Suppl 3:10-5; discussion 30-3. Review.

PMID:
8980862
4.

[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.

PMID:
18018602
5.

HIV infection and multidrug-resistant tuberculosis: the perfect storm.

Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Castro KG, Weyer K.

J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107. Review.

PMID:
17624830
6.

Multi-drug resistant tuberculosis burden and risk factors: an update.

Marahatta SB.

Kathmandu Univ Med J (KUMJ). 2010 Jan-Mar;8(29):116-25. Review.

PMID:
21209520
8.

Cost-effectiveness of treating multidrug-resistant tuberculosis.

Resch SC, Salomon JA, Murray M, Weinstein MC.

PLoS Med. 2006 Jul;3(7):e241.

9.

[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].

Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.

Kekkaku. 2003 Oct;78(10):611-7. Japanese.

PMID:
14621568
10.

Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.

Pablos-Mendez A, Gowda DK, Frieden TR.

Bull World Health Organ. 2002;80(6):489-95; discussion 495-500.

11.

Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.

Ahmad S, Mokaddas E.

Respir Med. 2009 Dec;103(12):1777-90. doi: 10.1016/j.rmed.2009.07.010. Epub 2009 Aug 5. Review.

12.

Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings.

Scano F, Vitoria M, Burman W, Harries AD, Gilks CF, Havlir D.

Int J Tuberc Lung Dis. 2008 Dec;12(12):1370-5.

PMID:
19017444
13.

Strategies against multidrug-resistant tuberculosis.

Loddenkemper R, Sagebiel D, Brendel A.

Eur Respir J Suppl. 2002 Jul;36:66s-77s. Review.

14.

[Multidrug-resistant tuberculosis].

Alcaide F, Santín M.

Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 13:54-60. Review. Spanish.

PMID:
19100168
15.

The resumption of consumption -- a review on tuberculosis.

Ducati RG, Ruffino-Netto A, Basso LA, Santos DS.

Mem Inst Oswaldo Cruz. 2006 Nov;101(7):697-714. Review.

16.

Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.

Prasad R.

Indian J Tuberc. 2010 Oct;57(4):180-91. Review.

PMID:
21141336
17.

Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.

Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ.

Clin Infect Dis. 2007 Nov 15;45(10):1290-5. Epub 2007 Oct 15.

PMID:
17968823
18.

Management of multidrug-resistant tuberculosis in children: a survival guide for paediatricians.

Schaaf HS, Marais BJ.

Paediatr Respir Rev. 2011 Mar;12(1):31-8. doi: 10.1016/j.prrv.2010.09.010. Epub 2010 Oct 14. Review.

PMID:
21172673
19.

Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control.

Matteelli A, Migliori GB, Cirillo D, Centis R, Girard E, Raviglion M.

Expert Rev Anti Infect Ther. 2007 Oct;5(5):857-71. Review.

PMID:
17914919
20.

Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.

Clin Infect Dis. 2008 Aug 15;47(4):496-502. doi: 10.1086/590005.

PMID:
18611154

Supplemental Content

Support Center